Tenofovir induced Fanconi syndrome: a possible pharmacokinetic interaction.

about

Incidence and risk factors for tenofovir-associated renal toxicity in HIV-infected patients.Reactivation of chronic hepatitis B during treatment with tenofovir disoproxil fumarate: drug interactions or low adherence?

P2860

Q41204065-819A8209-6FFB-4AFE-8DB4-2D0DE658F90A Q41505915-A4944CA0-417B-4204-AF1D-32D541C96161

P2860

Tenofovir induced Fanconi syndrome: a possible pharmacokinetic interaction.

Item

http://www.wikidata.org/entity/Q36865491

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Tenofovir induced Fanconi syndrome: a possible pharmacokinetic interaction.

@en

type

Item

label

Tenofovir induced Fanconi syndrome: a possible pharmacokinetic interaction.

@en

prefLabel

Tenofovir induced Fanconi syndrome: a possible pharmacokinetic interaction.

@en

P1476

Tenofovir induced Fanconi syndrome: a possible pharmacokinetic interaction.

@en

P2093

Asha N Shah

http://www.w3.org/2001/XMLSchema#string

Chetna Desai

http://www.w3.org/2001/XMLSchema#string

Jigar Kapadia

http://www.w3.org/2001/XMLSchema#string

Mira Desai

http://www.w3.org/2001/XMLSchema#string

R K Dikshit

http://www.w3.org/2001/XMLSchema#string

Samidh Shah

http://www.w3.org/2001/XMLSchema#string

Shivani Patel

http://www.w3.org/2001/XMLSchema#string

P2860

A method for estimating the probability of adverse drug reactions

Population pharmacokinetics of tenofovir in human immunodeficiency virus-infected patients taking highly active antiretroviral therapy.

Tenofovir-associated renal dysfunction in clinical practice: An observational cohort from western India

Tenofovir-associated acute and chronic kidney disease: a case of multiple drug interactions.

Acquired Fanconi's syndrome associated with tenofovir therapy.

Greater tenofovir-associated renal function decline with protease inhibitor-based versus nonnucleoside reverse-transcriptase inhibitor-based therapy.

Focusing on the preventability of adverse drug reactions.

P304

191-192

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.4103/0253-7613.108319

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23716900

http://www.w3.org/2001/XMLSchema#string

P932

3660936

http://www.w3.org/2001/XMLSchema#string

Tenofovir induced Fanconi syndrome: a possible pharmacokinetic interaction.

about

P2860

P2860

Tenofovir induced Fanconi syndrome: a possible pharmacokinetic interaction.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932